The pharmaceutical robots market is projected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2%.
The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016. Articulated robots are easier to align to multiple planes, simple to operate and maintain, and have a greater work envelope. Moreover, these robots provide a wide variety of payload capacities. These factors contribute to the high share of this segment.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=210985096
In 2016, Asia-Pacific accounted for the largest share of the global pharmaceutical robots market, followed by Europe, North America, and RoW. During the forecast period, Asia-Pacific is also expected to witness the highest growth. The large share and high growth of Asia-Pacific can be attributed to the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the industrial robots industry, and Japan’s Robot Strategy.
Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are some of the key players in the pharmaceutical robots market.